Effect of experimental hypo- and hyperthyroidism on serum adiponectin

Metabolism: Clinical and Experimental

Volumn 56, Issue 1, 2007, Pages 6-11

  Aragão, Christina Nogueira ^a   Souza, Luana Lopes ^a   Cabanelas, Adriana ^a   Oliveira, Karen Jesus ^a   Pazos Moura, Carmen Cabanelas ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; DRINKING WATER; GLUCOSE; INSULIN; LIOTHYRONINE; LIOTRIX; THIAMAZOLE; THYROTROPIN; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; CORRELATION FUNCTION; EPIDIDYMIS FAT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERTHYROIDISM; HYPOTHYROIDISM; INGUINAL REGION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIOTHYRONINE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RETROPERITONEUM; STATISTICAL SIGNIFICANCE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; WHITE ADIPOSE TISSUE;

ADIPONECTIN; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD GLUCOSE; GLUCOSE TOLERANCE TEST; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN; MALE; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 33845217960     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.08.015     Document Type: Article

References (35)

1. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
2. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP activated protein kinase. Nat Med 8 (2002) 1288-1295
3. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
4. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8 (2002) 731-737
5. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277 (2002) 25863-25866
6. Masaki T., Chiba S., Yasuda T., Tsubone T., Kakuma T., Shimomura I., et al. Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice. Diabetes 52 (2003) 2266-2273
7. Shklyaev S., Aslanidi G., Tennant M., Prima V., Kohlbrenner E., Kroutov V., et al. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci U S A 100 (2003) 14217-14222
8. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001) 941-946
9. Kadowaki T., and Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277 (2002) 25863-25866
10. Qi Y., Takahashi N., Hileman S.M., Patel H.R., Berg A.H., Pajvani U.B., et al. Adiponectin acts in the brain to decrease body weight. Nat Med 10 (2004) 524-529 [Erratum in Nat Med 10:64949, 2004]
11. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98 (2001) 2005-2010
12. Ma K., Cabrero A., Saha P.K., Kojima H., Li L., Chang B.H., et al. Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem 277 (2002) 34658-34661
13. Tomas E., Tsao T.S., Saha A.K., Murrey H.E., Zhang Cc C., Itani S.I., et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 99 (2002) 16309-16313
14. Berg A.H., Combs T.P., Du X., Brownlee M., and Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7 (2001) 947-953
15. Yaturu S., Prado S., and Grimes S.R. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem 93 (2004) 491-496
16. Saito T., Kawano T., Saito T., Ikoma A., Namai K., Tamemoto H., et al. Elevation of serum adiponectin levels in Basedow disease. Metabolism 54 (2005) 1461-1466
17. Santini F., Marsili A., Mammoli C., Valeriano R., Scartabelli G., Pelosini C., et al. Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. J Endocrinol Invest 27 (2004) RC5-RC7
18. Iglesias P., Alvarez Fidalgo P., Codoceo R., and Diez J.J. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol 59 (2003) 621-629
19. Fernandez-Real J.M., Lopez-Bermejo A., Casamitjana R., and Ricart W. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab 88 (2003) 2714-2718
20. Fujimoto N., Matsuo N., Sumiyoshi H., Yamaguchi K., Saikawa T., Yoshimatsu H., et al. Adiponectin is expressed in the brown adipose tissue and surrounding immature tissues in mouse embryos. Biochim Biophys Acta 1731 (2005) 1-12
21. Fasshauer M., Klein J., Neumann S., Eszlinger M., and Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290 (2002) 1084-1089
22. Ortiga-Carvalho T.M., Polak J., McCann S., and Pazos-Moura C.C. Effect of thyroid hormones on pituitary neuromedin B and possible interaction between thyroid hormones and neuromedin B on thyrotropin secretion. Regul Pept 67 (1996) 47-53
23. Iacobellis G., Ribaudo M.C., Zappaterreno A., Iannucci C.V., and Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol 62 (2005) 487-491
24. Milan G., Granzotto M., Scarda A., Calcagno A., Pagano C., Federspil G., et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 10 (2002) 1095-1103
25. Arawaka N., Daimon M., Oizumi T., Jimbu Y., Kameda W., Yamaguchi H., et al. Correlation between change in body weight rather than current body weight and change in serum adiponectin levels in a Japanese population-the Funagata study. Metabolism 55 (2006) 324-330
26. Wolfe B.E., Jimerson D.C., Orlova C., and Mantzoros C.S. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol 61 (2004) 332-338
27. Pannacciulli N., Vettor R., Milan G., Granzotto M., Catucci A., Federspil G., et al. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 88 (2003) 1748-1752
28. Delporte M.L., Brichard S.M., Hermans M.P., Beguin C., and Lambert M. Hyperadiponectinemia in anorexia nervosa. Clin Endocrinol 58 (2003) 22-29
29. Housova J., Anderlova K., Krizova J., Haluzikova D., Kremen J., Kumstyrova T., et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 90 (2005) 1366-1370
30. Misra M., Miller K.K., Almazan C., Ramaswamy K., Aggarwal A., Herzog D.B., et al. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab 89 (2004) 3486-3495
31. Tagami T., Satoh N., Usui T., Yamada K., Shimatsu A., and Kuzuya H. Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 89 (2004) 1833-1837
32. Abbasi F., Chang S.A., Chu J.W., Ciaraldi T.P., Lamendola C., McLaughlin T., et al. Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol 290 (2006) R139-R144
33. Kantartzis K., Fritsche A., Tschritter O., Thamer C., Haap M., Schafer S., et al. The association between plasma adiponectin and insulin sensitivity in humans depends on obesity. Obes Res 13 (2005) 1683-1691
34. Chiovato L., Barbesino G., and Pinchera A. Graves' disease. In: DeGroot L.J., and Jameson J.L. (Eds). Endocrinology vol. 2 (2001), WB Saunders Company, Philadelphia (Pa) 1422-1449
35. Fukucki M., Shimabukuro M., Shimajiri Y., Oshiro Y., Higa M., Akamine H., et al. Evidence for a deficient pancreatic B-cell response in a rat model of hyperthyroidism. Life Sci 71 (2002) 1059-1070